Literature DB >> 21527521

Protein kinase C mediates platelet secretion and thrombus formation through protein kinase D2.

Olga Konopatskaya1, Sharon A Matthews, Matthew T Harper, Karen Gilio, Judith M E M Cosemans, Christopher M Williams, Maria N Navarro, Deborah A Carter, Johan W M Heemskerk, Michael Leitges, Doreen Cantrell, Alastair W Poole.   

Abstract

Platelets are highly specialized blood cells critically involved in hemostasis and thrombosis. Members of the protein kinase C (PKC) family have established roles in regulating platelet function and thrombosis, but the molecular mechanisms are not clearly understood. In particular, the conventional PKC isoform, PKCα, is a major regulator of platelet granule secretion, but the molecular pathway from PKCα to secretion is not defined. Protein kinase D (PKD) is a family of 3 kinases activated by PKC, which may represent a step in the PKC signaling pathway to secretion. In the present study, we show that PKD2 is the sole PKD member regulated downstream of PKC in platelets, and that the conventional, but not novel, PKC isoforms provide the upstream signal. Platelets from a gene knock-in mouse in which 2 key phosphorylation sites in PKD2 have been mutated (Ser707Ala/Ser711Ala) show a significant reduction in agonist-induced dense granule secretion, but not in α-granule secretion. This deficiency in dense granule release was responsible for a reduced platelet aggregation and a marked reduction in thrombus formation. Our results show that in the molecular pathway to secretion, PKD2 is a key component of the PKC-mediated pathway to platelet activation and thrombus formation through its selective regulation of dense granule secretion.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21527521      PMCID: PMC4773892          DOI: 10.1182/blood-2010-10-312199

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  42 in total

1.  Protein kinase D1 and the beta 1 integrin cytoplasmic domain control beta 1 integrin function via regulation of Rap1 activation.

Authors:  Ricardo B Medeiros; Deborah M Dickey; Heekyoung Chung; Angie C Quale; Lakshmi R Nagarajan; Daniel D Billadeau; Yoji Shimizu
Journal:  Immunity       Date:  2005-08       Impact factor: 31.745

2.  SDF-1-induced adhesion of monocytes to vascular endothelium is modulated by azelnidipine via protein kinase C inhibition.

Authors:  Keiko Takahashi; Kentaro Shimokado; Masayuki Yoshida
Journal:  Eur J Pharmacol       Date:  2006-09-23       Impact factor: 4.432

Review 3.  PKD at the crossroads of DAG and PKC signaling.

Authors:  Qiming J Wang
Journal:  Trends Pharmacol Sci       Date:  2006-05-06       Impact factor: 14.819

4.  Vascular endothelial growth factor induces protein kinase D-dependent production of proinflammatory cytokines in endothelial cells.

Authors:  Qin Hao; Linping Wang; Hua Tang
Journal:  Am J Physiol Cell Physiol       Date:  2009-01-28       Impact factor: 4.249

5.  A novel kinase inhibitor establishes a predominant role for protein kinase D as a cardiac class IIa histone deacetylase kinase.

Authors:  Lauren Monovich; Richard B Vega; Erik Meredith; Karl Miranda; Chang Rao; Michael Capparelli; Douglas D Lemon; Dillon Phan; Keith A Koch; Joseph A Chapo; David B Hood; Timothy A McKinsey
Journal:  FEBS Lett       Date:  2009-12-14       Impact factor: 4.124

6.  Novel protein kinase D inhibitors cause potent arrest in prostate cancer cell growth and motility.

Authors:  Courtney R Lavalle; Karla Bravo-Altamirano; Karthik V Giridhar; Jun Chen; Elizabeth Sharlow; John S Lazo; Peter Wipf; Q Jane Wang
Journal:  BMC Chem Biol       Date:  2010-05-05

7.  Functional divergence of platelet protein kinase C (PKC) isoforms in thrombus formation on collagen.

Authors:  Karen Gilio; Matthew T Harper; Judith M E M Cosemans; Olga Konopatskaya; Imke C A Munnix; Lenneke Prinzen; Michael Leitges; Qinghang Liu; Jeffery D Molkentin; Johan W M Heemskerk; Alastair W Poole
Journal:  J Biol Chem       Date:  2010-05-17       Impact factor: 5.157

8.  Sequential protein kinase C (PKC)-dependent and PKC-independent protein kinase D catalytic activation via Gq-coupled receptors: differential regulation of activation loop Ser(744) and Ser(748) phosphorylation.

Authors:  Rodrigo Jacamo; James Sinnett-Smith; Osvaldo Rey; Richard T Waldron; Enrique Rozengurt
Journal:  J Biol Chem       Date:  2008-03-12       Impact factor: 5.157

Review 9.  Protein kinase Calpha: disease regulator and therapeutic target.

Authors:  Olga Konopatskaya; Alastair W Poole
Journal:  Trends Pharmacol Sci       Date:  2009-12-05       Impact factor: 14.819

10.  alpha v beta3 and alpha5beta1 integrin recycling pathways dictate downstream Rho kinase signaling to regulate persistent cell migration.

Authors:  Dominic P White; Patrick T Caswell; Jim C Norman
Journal:  J Cell Biol       Date:  2007-05-07       Impact factor: 10.539

View more
  18 in total

1.  Protein kinase Cδ mediates the activation of protein kinase D2 in platelets.

Authors:  Dheeraj Bhavanasi; Soochong Kim; Lawrence E Goldfinger; Satya P Kunapuli
Journal:  Biochem Pharmacol       Date:  2011-06-28       Impact factor: 5.858

2.  CGX1037 is a novel PKC isoform delta selective inhibitor in platelets.

Authors:  Dheeraj Bhavanasi; John C Kostyak; John Swindle; Laurie E Kilpatrick; Satya P Kunapuli
Journal:  Platelets       Date:  2014-01-16       Impact factor: 3.862

3.  Mechanism of platelet dense granule biogenesis: study of cargo transport and function of Rab32 and Rab38 in a model system.

Authors:  Andrea L Ambrosio; Judith A Boyle; Santiago M Di Pietro
Journal:  Blood       Date:  2012-08-27       Impact factor: 22.113

4.  12-lipoxygenase activity plays an important role in PAR4 and GPVI-mediated platelet reactivity.

Authors:  J Yeung; P L Apopa; J Vesci; M Stolla; G Rai; A Simeonov; A Jadhav; P Fernandez-Perez; D J Maloney; O Boutaud; T R Holman; M Holinstat
Journal:  Thromb Haemost       Date:  2013-06-20       Impact factor: 5.249

5.  mTOR regulates GPVI-mediated platelet activation.

Authors:  Longsheng Wang; Gang Liu; Nannan Wu; Baiyun Dai; Shuang Han; Qiaoyun Liu; Fang Huang; Zhihua Chen; Weihong Xu; Dajing Xia; Cunji Gao
Journal:  J Transl Med       Date:  2021-05-10       Impact factor: 5.531

6.  Protein kinase D isoforms are dispensable for integrin-mediated lymphocyte adhesion and homing to lymphoid tissues.

Authors:  Sharon A Matthews; Hwee San Lek; Vicky L Morrison; Matthew G Mackenzie; Marouan Zarrouk; Doreen Cantrell; Susanna C Fagerholm
Journal:  Eur J Immunol       Date:  2012-05       Impact factor: 5.532

7.  Phosphoproteomic identification of vasopressin-regulated protein kinases in collecting duct cells.

Authors:  Arnab Datta; Chin-Rang Yang; Karim Salhadar; Euijung Park; Chung-Lin Chou; Viswanathan Raghuram; Mark A Knepper
Journal:  Br J Pharmacol       Date:  2021-02-14       Impact factor: 9.473

8.  The kinase PKD3 provides negative feedback on cholesterol and triglyceride synthesis by suppressing insulin signaling.

Authors:  Alexander E Mayer; Mona C Löffler; Angel E Loza Valdés; Werner Schmitz; Rabih El-Merahbi; Jonathan Trujillo Viera; Manuela Erk; Thianzhou Zhang; Ursula Braun; Mathias Heikenwalder; Michael Leitges; Almut Schulze; Grzegorz Sumara
Journal:  Sci Signal       Date:  2019-08-06       Impact factor: 8.192

9.  Thyrotropin regulates IL-6 expression in CD34+ fibrocytes: clear delineation of its cAMP-independent actions.

Authors:  Nupur Raychaudhuri; Roshini Fernando; Terry J Smith
Journal:  PLoS One       Date:  2013-09-25       Impact factor: 3.240

10.  Absence of platelet phenotype in mice lacking the motor protein myosin Va.

Authors:  Matthew T Harper; Marion T J van den Bosch; Ingeborg Hers; Alastair W Poole
Journal:  PLoS One       Date:  2013-01-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.